While venture investment dollars worldwide edged higher in the first three months of 2023, the number of deals continued to slide from the previous quarter. . . . → Read More: Infographic – Q1 2023 Venture Funds Hunker Down
|
|||||
While venture investment dollars worldwide edged higher in the first three months of 2023, the number of deals continued to slide from the previous quarter. . . . → Read More: Infographic – Q1 2023 Venture Funds Hunker Down A venture capital company specializing in early-stage investments in life science, health, and technology start-ups announced a new $850 million fund. . . . → Read More: Health, Tech Venture Investor Adds $850M Fund A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round. . . . → Read More: Seaweed Biomaterials Start-Up Gains $5M in Early Funds A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds As our infographic indicates, generative A.I. can be applied in a range of industries, particularly in design and discovery functions. . . . → Read More: Infographic – Six Generative A.I. Applications A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M A new report on venture funding for artificial intelligence start-ups shows global investment dollars rose in the fourth quarter of 2022, the first increase in 18 months. . . . → Read More: Infographic – A.I. Venture Funds Tick Up in Q4 2022 A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds. . . . → Read More: Post-Surgical Fluid Cancer Analytics Company Gains $8M A new company is underway developing drugs to treat PTSD and other disorders with psychoactive compounds claimed to be safer than current psychedelics. . . . → Read More: Psychoactive Drug Start-Up Raises $40M in Early Funds A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds. . . . → Read More: Bio-Electric Regeneration Company Adds $8M in Seed Funds |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |